Evidence map›Paper›PMID 31024510›Full record

ArticleFrontiers in microbiology2019

Estimating HIV-1 Genetic Diversity in Brazil Through Next-Generation Sequencing.

Brunna M Alves, Juliana D Siqueira, Isabel M Prellwitz, Ornella M Botelho, Vanusa P Da Hora, Sabri Sanabani, Patrícia Recordon-Pinson, Hervé Fleury, Esmeralda A Soares, Marcelo A Soares

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Current landscape and future directions of synthetic biology in South America.Frontiers in bioengineering and biotechnology · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Brunna M AlvesPrograma de Oncovirologia, Instituto Nacional de Câncer, Rio de Janeiro, Brazil.
Juliana D SiqueiraPrograma de Oncovirologia, Instituto Nacional de Câncer, Rio de Janeiro, Brazil.
Isabel M PrellwitzPrograma de Oncovirologia, Instituto Nacional de Câncer, Rio de Janeiro, Brazil.
Ornella M BotelhoPrograma de Oncovirologia, Instituto Nacional de Câncer, Rio de Janeiro, Brazil.
Vanusa P Da HoraLaboratório de Biologia Molecular, Escola de Medicina, Universidade Federal do Rio Grande, Rio Grande do Sul, Brazil.
Sabri SanabaniLIM-3, Hospital das Clinicas FMUSP, Faculty of Medicine, University of São Paulo, São Paulo, Brazil.
Patrícia Recordon-PinsonCNRS MFP-UMR 5234, University Hospital of Bordeaux, University of Bordeaux, Bordeaux, France.
Hervé FleuryCNRS MFP-UMR 5234, University Hospital of Bordeaux, University of Bordeaux, Bordeaux, France.
Esmeralda A SoaresPrograma de Oncovirologia, Instituto Nacional de Câncer, Rio de Janeiro, Brazil.
Marcelo A SoaresPrograma de Oncovirologia, Instituto Nacional de Câncer, Rio de Janeiro, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Approximately 36.7 million people were living with the human immunodeficiency virus (HIV) at the end of 2016 according to UNAIDS, representing a global prevalence rate of 0.8%. In Brazil, an HIV prevalence of 0.24% has been estimated, which represents approximately 830,000 individuals living with the virus. As a touristic and commercial hub in Latin America, Brazil harbors an elevated HIV genetic variability, further contributed by the selective pressure exerted by the host immune system and by antiretroviral treatment. Through the progress of the next-generation sequencing (NGS) techniques, it has been possible to expand the study of HIV genetic diversity, evolutionary, and epidemic processes, allowing the generation of HIV complete or near full-length genomes (NFLG) and improving the characterization of intra- and interhost diversity of viral populations. Greater sensitivity in the detection of viral recombinant forms represents one of the major improvements associated with this development. It is possible to identify unique or circulating recombinant forms using the near full-length viral genomes with increasing accuracy. It also permits the characterization of multiple viral infections within individual hosts. Previous Brazilian studies using NGS to analyze HIV diversity were able to identify several distinct unique and circulating recombinant forms and evidenced dual infections. These data unveiled unprecedented high rates of viral recombination and highlighted that novel recombinants are continually arising in the Brazilian epidemic. In the pooled analysis depicted in this report, HIV subtypes have been determined from HIV-positive patients in five states of Brazil with some of the highest HIV prevalence, three in the Southeast (Rio de Janeiro, São Paulo, and Minas Gerais), one in the Northeast (Pernambuco) and one in the South (Rio Grande do Sul). Combined data analysis showed a significant prevalence of recombinant forms (29%; 101/350), and a similar 26% when only NFLGs were considered. Moreover, the analysis was able to evidence the occurrence of multiple infections in some individuals. Our data highlight the great HIV genetic diversity found in Brazil and unveils a more accurate scenario of the HIV evolutionary dynamics in the region.

Indexed as

genetic diversityHIV-1NFLGNGSsubtype

Identifiers

PMID31024510
PMCPMC6465556

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.